TARRYTOWN, N.Y.--(BUSINESS WIRE)--Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced that Paul J. Maddon, M.D., Ph.D., Progenics’ Founder, Chief Executive Officer and Chief Science Officer, will ring the NASDAQ stock market opening bell on Monday, November 19, 2007 to celebrate the company’s ten year listing on NASDAQ. Following the opening on November 19th, Dr. Maddon will reflect on Progenics’ accomplishments since incorporating and operating as a public company in November 1997.
